HOME >> BIOLOGY >> NEWS
2006 World Food Prize recipients to be recognized at soils congress

ocked Brazil's tremendous potential for food production. Their pioneering advancements made agricultural development possible in the Cerrado."

Dr. McClung's pioneering soil fertility research in the 1950s analyzed the complexity of Cerrado soils and showed that a transformation of the region was possible. His work uncovered an innovative soil improvement process to correct the drastic nutrient depletion of the Cerrado and counteract aluminum toxicity in the region's highly acidic soils, concluding that the Cerrado could be made suitable for production of crops as diverse as coffee, soybeans, citrus and corn.

Beginning his career as Secretary of Agriculture in the state of Minas Gerais in the early 1970s, Alysson Paolinelli created a new model for rural credit and other development programs. He envisioned and oversaw the creation of the institutional and financial infrastructure that enabled crop and livestock production to flourish in the Cerrado. As Minister of Agriculture from 1974 to 1979, he was instrumental in establishing the Brazilian Agricultural Research Corporation (EMBRAPA) to provide a system of technical, administrative and research support to farmers and agribusinesses.

Edson Lobato was a leader in evaluating and carrying out studies of Cerrado soil fertility and agricultural production. During the course of his 30-year career as an agronomy engineer and administrator at EMBRAPA, Lobato led Cerrado soil fertility and agronomy research as it expanded to include soil microbiology, soil management, and crop management.


'"/>

Contact: Sara Uttech
suttech@soils.org
608-268-4948
American Society of Agronomy
23-Jun-2006


Page: 1 2

Related biology news :

1. World Wildlife Fund warns against iron dumping experiment near the Galapagos Islands
2. Worlds first X-ray free electron laser is on course to completion
3. Worlds leading scientists announce creation of Encyclopedia of Life
4. Prize winners announced at ISNs World Congress of Nephrology
5. World first test potential to identify breast cancer patients who will react badly to radiotherapy
6. Worlds top engineers in San Antonio for system of systems conference
7. OneWorld Health selects Odyssey Research for phase 4 study in India
8. MicrobeWorld podcast wins another award
9. International Astronautical Federation joins project to protect World Heritage sites
10. Press registration -- World Congress of Nephrology, April 21-25, 2007, Rio de Janeiro, Brazil
11. Nature Genetics and the International Society of Nephrology come to Danvers on World Kidney Day

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: World Food Prize recipients recognized soils congress

(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... NOVATO, Calif. , May 21, 2015 /PRNewswire-USNewswire/ ... Orrin Hatch (R-UT) and Amy ... Product Extensions Now Accelerating Cures & Treatments, or ... 150 rare disease patient advocacy organizations, this bipartisan ... effective, and affordable medicines to rare disease patients ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: